Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Avalo Therapeutics, Inc (AVTX)  
$0.43 0.00 (0.00%) as of 4:30 Thu 7/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 112,320,000
Market Cap: 48.31(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4301 - $0.4301
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 37,351 662,763
Total Buy Value $0 $0 $139,843 $643,635
Total People Bought 0 0 3 4
Total Buy Transactions 0 0 10 32
Total Shares Sold 0 0 5,291,542 5,291,542
Total Sell Value $0 $0 $3,199,077 $3,199,077
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 4 4
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 440
  Page 18 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kolluri Krishna Kittu 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 594,245 594,245     -
   Florence Anthony A. Jr. 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 594,245 594,245     -
   Kerins Patrick J 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 594,245 594,245     -
   Baskett Forest 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 594,245 594,245     -
   Nea 14 Gp, Ltd 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 D/D 594,245 594,245     -
   Barrett M James 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 594,245 594,245     -
   Foley Todd 10% Owner   –       –       •   2015-10-20 4 A $0.00 $0 I/I 595,436 595,436     -
   Harrison Seth Loring Director   –       •       •   2015-10-20 4 A $0.00 $0 D/D 595,436 595,436     -
   Marcus Ronald Chief Medical Officer   •       –      –    2015-10-20 4 B $0.00 $0 D/D 30,617 36,000 2.66     -
   Marcus Ronald Chief Medical Officer   •       –      –    2015-10-20 4 A $0.00 $0 D/D 5,383 5,383     -
   Blech Isaac Director   –       •       •   2015-10-20 4 A $0.00 $0 I/I 182,030 385,452     -
   Blech Isaac Director   –       •       •   2015-10-20 4 A $0.00 $0 D/D 5,952 203,452     -
   Blech Isaac Director   –       •       •   2015-10-14 3 IO $0.00 $0 D/D 0 197,500     -
   Paterson Blake M CEO and PresidentOfficer   •       •      –    2015-10-14 3 IO $0.00 $0 D/D 0 56,071     -
   Bauer Eugene A Director   –       •      –    2015-10-14 3 IO $0.00 $0 D/D 0 26,785     -

  440 Records found
  Previous  10  11  12  13  14  15  16  17  18    
  Page 18 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed